.

John C. Williams - Co-Founder and Member of Scientific Advisory Board

John is a co-founder of Akriveia and member of the Scientific Advisory Board.

John is professor of molecular medicine at the Beckman Research Institute of the City of Hope, where he also serves as a member of the Developmental Cancer Therapeutics Program as well as Co-Director of the Drug Discovery and Structural Biology Core.

The main focus of John’s research centers on the application of structural and biophysical methods to understand the biological role of multivalency and energy additivity on multicomponent, macromolecular complexes and how to manipulate these properties to develop novel, highly specific agonists and antagonists. His lab also discovered the meditope binding site while investigating alternative methods of modulating properties of protein therapeutics.

John earned his B.S. in chemistry from the University of California at Santa Cruz and his Ph.D. in chemistry from Columbia University. He was an Alexander von Humboldt postdoctoral fellow at the European Molecular Biology Laboratories in Heidelberg, Germany and an HHMI and Leukemia and Lymphoma Society Special Fellow at Columbia-Presbyterian Medical Center.

John jointly developed the concepts underlying Akriveia’s technology with Uli Rodeck.